Next-generation smallpox vaccine being stockpiled

Question of the Day

Should Congress make English the official language of the U.S.?

View results

WASHINGTON (AP) - A Danish company has delivered the first 1 million doses of a next-generation smallpox vaccine to the U.S. national stockpile, a vaccine reserved for people with weakened immune systems.

The federal government has ordered 20 million doses of Bavarian Nordic’s Imvamune, a vaccine developed in part with U.S. research money as part of the nation’s preparations in case of a bioterrorist attack.

The government has long stockpiled smallpox vaccine against such a possibility. But the conventional vaccine, made with a live virus that’s a relative of smallpox, isn’t safe for people with weakened immune systems. Imvamune is made of a different strain of the virus, targeted for the immune-compromised because it cannot multiply in human cells.

Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

blog comments powered by Disqus
TWT Video Picks